Universitätsklinikum Düsseldorf

Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort. (2025) Györfi AH, Filla T, Polzin A, Tascilar K, Buch M, Tröbs M, Matei AE, et al. Journal article Preferred Working Time Models and Equal Opportunities in Gynecology and Obstetrics: Results of the Systematic Trinational FARBEN Survey (2025) Tauber N, Amann N, Foessleitner P, Klee A, Becker C, Kiblawi R, Göpfert M, et al. Journal article Personality Functioning in Inpatients With Eating Disorders: Association With Symptom Severity and Treatment Outcome (2025) Heinzmann S, Etzler S, Hartmann A, Klein EM, Herpertz S, Pape M, Heinzmann S, et al. Journal article A multicenter cohort study on the efficacy, retention, and tolerability of cenobamate in patients with developmental and epileptic encephalopathies (2025) Buhleier E, Schubert-Bast S, Knake S, von Podewils F, Hamer H, Melzer N, Kurlemann G, et al. Journal article Implant-based reconstruction and adjuvant radiotherapy in breast cancer patients—current status and DEGRO recommendations (2025) Piroth MD, Krug D, Baumann R, Strnad V, Borm K, Combs S, Corradini S, et al. Journal article Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer (2025) Conforti F, Nekljudova V, Sala I, Ascari R, Solbach C, Untch M, Denkert C, et al. Journal article Trio Exome Sequencing in VACTERL Association (2025) Ćomić J, Tilch E, Riedhammer KM, Brugger M, Brunet T, Eyring K, Vill K, et al. Journal article Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025) Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al. Journal article Factors influencing pathological complete response and tumor regression in neoadjuvant radiotherapy and chemotherapy for high-risk breast cancer (2024) Haussmann J, Budach W, Nestle-Krämling C, Wollandt S, Jazmati D, Tamaskovics B, Corradini S, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article